Stablecoin Development Corporation

Day range

$0.89 – $0.93

Open

$0.91

Prev close

$0.90

Volume

1.08M

Market cap

$65.56M

Shares out

73.12M

P/E

0.12

P/S

9.66

P/B

0.36

P/FCF

—

ROE

308.3%

ROA

298.4%

Debt/Equity

0.00

Div yield

0.00%

As of Nov 5, 2026

• Business updateOct 29, 2026

  As discussed in the press release, the Company engages in SKY-related on-chain activities, including staking. As of October 26, 2026, the Company held approximately 2.33 billion SKY tokens.

• Preliminary resultsOct 5, 2026

  All figures are preliminary and unaudited, remain subject to the completion of the Company's quarter-end closing procedures... As of September 30, 2026, the Company held 2,321,079,862 SKY tokens... [and] the fair value of the Company's SKY holdings ... was approximately $180.2 million, as compared to approximately $119.2 million as of June 30, 2026.

• Executive compensation changeSep 8, 2026

  As a newly appointed director of the Company, David Garcia Rios will receive the Company's standard director compensation package, which consists of annual compensation of $40,000 in cash, payable quarterly in arrears and prorated for any partial year of service.

• Executive compensation changeJul 17, 2026

  On April 1, 2026, the Compensation Committee of the Board (the "Compensation Committee") approved a grant to Mr. Blynn of 1,400,000 time-based restricted stock units ("RSUs") under the NovaBay Pharmaceuticals, Inc. 2026 Equity Incentive Plan (the "2026 Plan"). Mr. Blynn's RSUs will vest in equal one-third installments, with the first installment vesting on February 16, 2027, the second installment vesting on January 16, 2028 and the third installment vesting on January 16, 2029.

• Warrant or conversionJun 17, 2026

  Following the amendment of the October 2025 Pre-Funded Warrants, each of R01 and Framework fully exercised their respective October Pre-Funded Warrants on a cashless basis. As such, each of R01 and Framework received 11,307,300 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"), after the withholding of 24,720 shares of Common Stock, representing the cashless exercise price, resulting in the issuance by the Company of an aggregate of 22,614,600 shares of Common Stock.

Days to cover

1.0

Short interest

1.27M

Avg volume

47.12M

As of Oct 15, 2026 · reported to FINRA twice monthly.

• SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
  negativeGlobeNewswire Inc.· Aug 3, 2026
• AGIG: Abbott Cooper PLLC Announces Investigation on Behalf of Abundia Global Impact Group, Inc. (Formerly Houston American Energy Corp.) Stockholders
  negativeGlobeNewswire Inc.· Jul 8, 2026
• SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders
  negativeGlobeNewswire Inc.· Jun 17, 2026